Mayo Clinic Laboratory and pathology research roundup: March 8
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Androgen deprivation therapy use and duration with definitive radiotherapy for localized prostate cancer: an individual patient data meta-analysis.
Randomised trials have investigated various androgen deprivation therapy (ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate cancer. This individual patient data meta-analysis of relevant randomised trials aimed to quantify the benefit of these interventions in aggregate and in clinically relevant subgroups.
Published to PubMed This Week
- Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.
Blood - IMPROvE-CED Trial: Intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and nonobstructive coronary arteries.
Circulation Research - Thymic Carcinomas - A concise multidisciplinary update on recent developments from the thymic carcinoma working group of the international thymic malignancy interest group.
Journal of Thorac Oncology - Reprint of "Introduction to 2021 WHO classification of thoracic tumors".
Journal of Thorac Oncology - LGI1 antibody encephalitis: acute treatment comparisons and outcome.
Journal of Neurology, Neurosurgery, and Psychiatry - Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS-RS) but not in MDS/MPN-RS-T.
American Journal of Hematology - Outcomes for ESD of pathologically staged T1b esophageal cancer: A multi-center study.
Gastrointestinal Endoscopy - Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia.
British Journal of Haemotology - Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
British Journal of Haemotology - Particle therapy for breast cancer.
Cancers
